New device to improve safety and accuracy of blood collection from
25 March 2010
BD Diagnostics, a segment of BD (Becton, Dickinson and
Company), has launched the BD Microtainer MAP Microtube for Automated
Process for haematology testing.
This new product is designed to improve the safety, accuracy and
turnaround time of capillary blood collection and testing in
patients with veins that can be difficult to access, such as
infants, children, oncology patients and the elderly.
The new product is also the first microtube to be fully compatible
with most automated haematology instruments, reducing turnaround
time and costs associated with sample transfer and re-labeling.
“Clinical laboratories are focused on preventing specimen
identification errors that can lead to misdiagnosis of patients. We
at BD are pleased to introduce the BD Microtainer MAP product to
address this healthcare issue,” said Tom Polen, President, BD
Diagnostics — Preanalytical Systems. “BD is committed to continuing
our history of innovation in helping improve patient safety and
healthcare worker safety, while enhancing workflow efficiency.”
The BD Microtainer MAP tube
(see photo on right) is the first low-volume collection
system to accommodate standard, full-size patient identification
labels, thus reducing the risk of labeling errors. This feature
offers a significant improvement over traditional microcollection
tubes, which are incompatible with standard labels due to their
size. This disparity can lead to dangerous labeling errors that may
result in misdiagnosis and incorrect patient treatment.
The preanalytical phase is a critical step in the diagnostic
process, with significant impact to patient health, healthcare
worker safety, and workflow efficiencies. Historically, low-volume
capillary blood collection has increased test result turnaround time
due to incompatibility with automated testing instruments and a
higher risk of patient identification errors.
The innovative design of the BD Microtainer MAP tube enables
automated processing with 81 percent less blood than venous systems,
improving test turnaround time and laboratory efficiency. This is a
critical improvement for patients from whom it is difficult to
obtain a sufficient blood sample to perform critical diagnostic